Form 4 for RMD ResMed|
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-11 · accession 0000943819-25-000116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-13 | 2025-11-11 | RMD | Farrell Michael J. | COB, CEO, Dir | F - Tax | $250.10 | -7,897 | 460.0K | -2% | -$1.97M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2025-11-11 | F | D | 3,459.33 | $250.10 | 462,175 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2025-11-11 | F | D | 2,231.55 | $250.10 | 465,634 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2025-11-11 | F | D | 2,205.70 | $250.10 | 459,969 | D | — | — |